FDA to Reassess Safety of SSRIs in Pregnancy and RSV Shots Amid Growing Concerns
Original framing: “STAT+: In first speech to her FDA staff, Høeg says she’ll scrutinize RSV shots and SSRIs in pregnancy” — STAT News
The original framing omits the historical context of pharmaceutical safety concerns, as well as the perspectives of marginalized communities who may be impacted by these policies. Additionally, the article fails to explore the structural causes of pharmaceutical safety issues, such as regulatory capture and industry influence.
Medium structural omission detected in mainstream coverage.
This narrative was produced by STAT News, a reputable healthcare publication, for an audience interested in pharmaceutical policy and regulatory affairs. The framing serves to inform and engage this audience, while potentially obscuring the perspectives of marginalized communities who may be disproportionately affected by these policies.
The article relies on scientific evidence to support its claims, but could benefit from a more nuanced discussion of the limitations and uncertainties of pharmaceutical safety research.